Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule

NCT01641991 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

328

Enrollment

NIH

Sponsor class

Conditions

Bacillus Anthracis (Anthrax)

Interventions

BIOLOGICAL: BioThrax®
BIOLOGICAL: BioThrax®

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)